Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 9.71 is 23% above its 5-year average of 7.91, near the low end of its 5-year range (2.07–31.15).
As of the fiscal period ended Tuesday, June 30, 2026. 87.34% above its 12-month average of 5.18.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 9.71.
CURRENT RATIO
9.71
CURRENT RATIO AVG TTM
5.18
CURRENT RATIO AVG 3Y
5.33
CURRENT RATIO AVG 5Y
7.91
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+87.34%
CURRENT VS 3Y AVG
+82.13%
CURRENT VS 5Y AVG
+22.72%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.17
median of 462 covered companies
CURRENT VS SECTOR MEDIAN
+206.27%
vs the sector median at left
ALX Oncology Holdings Inc.
Market Cap
$162.82M
Current Ratio
9.71
TTM Avg
5.18
3Y Avg
5.33
5Y Avg
7.91
Market Cap
$153.84M
Current Ratio
2.47
TTM Avg
5.27
3Y Avg
13.16
5Y Avg
16.37
Market Cap
$172.99M
Current Ratio
11.22
TTM Avg
14.99
3Y Avg
15.44
5Y Avg
13.43
Market Cap
$152.45M
Current Ratio
15.62
TTM Avg
10.23
3Y Avg
11.93
5Y Avg
11.24
Market Cap
$152.16M
Current Ratio
5.55
TTM Avg
4.34
3Y Avg
4.83
5Y Avg
5.46
Market Cap
$174.17M
Current Ratio
12.82
TTM Avg
9.83
3Y Avg
6.43
5Y Avg
5.45
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ALX Oncology Holdings Inc. (ALXO) | $162.82M | 9.71 | 5.18 | 5.33 | 7.91 |
| Inogen, Inc. (INGN)vs › | $160.82M | 2.74 | 2.77 | 3.26 | 3.97 |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $153.84M | 2.47 | 5.27 | 13.16 | 16.37 |
| Compass Therapeutics, Inc. (CMPX)vs › | $172.99M | 11.22 | 14.99 | 15.44 | 13.43 |
| Coherus Oncology, Inc. (CHRS)vs › | $173.04M | 1.77 | 1.33 | 1.71 | 2.63 |
| Anavex Life Sciences Corp. (AVXL)vs › | $152.45M | 15.62 | 10.23 | 11.93 | 11.24 |
| Cardiol Therapeutics Inc. (CRDL)vs › | $152.16M | 5.55 | 4.34 | 4.83 | 5.46 |
| Precision BioSciences, Inc. (DTIL)vs › | $174.17M | 12.82 | 9.83 | 6.43 | 5.45 |
| Codexis, Inc. (CDXS)vs › | $149.51M | 3.06 | 4.00 | 3.48 | 4.36 |
| Cue Biopharma, Inc. (CUE)vs › | $176.96M | 1.25 | 2.29 | 3.57 | 4.16 |
Current Ratio
9.71
Quick Ratio
9.71
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 9.71 |
| 2026-03-31 | 7.21 |
| 2025-12-31 | 2.07 |
| 2025-09-30 | 2.40 |
| 2025-06-30 | 4.52 |
| 2025-03-31 | 5.47 |
| 2024-12-31 | 7.26 |
| 2024-09-30 | 4.82 |
| 2024-06-30 | 4.39 |
| 2024-03-31 | 5.21 |
| 2023-12-31 | 5.24 |
| 2023-09-30 | 5.66 |
| 2023-06-30 | 12.49 |
| 2023-03-31 | 10.62 |
| 2022-12-31 | 9.57 |
| 2022-09-30 | 11.52 |
| 2022-06-30 | 13.23 |
| 2022-03-31 | 21.00 |
| 2021-12-31 | 24.00 |
| 2021-09-30 | 31.15 |
| 2021-06-30 | 29.49 |
| 2021-03-31 | 30.60 |
| 2020-12-31 | 70.28 |
| 2020-09-30 | 36.46 |
| 2020-06-30 | 13.04 |
| 2020-03-31 | 26.92 |
| 2019-12-31 | 1.97 |
| 2019-09-30 | 0.00 |
| 2019-06-30 | 0.00 |
| 2019-03-31 | 0.00 |
